Aptevo Therapeutics Inc. (APVO)
USD 4.29
(2.14%)
USD 4.29
(2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.73 Million | -21.02 Million | -21.67 Million | -29.31 Million | -42.38 Million | -51.42 Million |
| Net Income | -18.65 Million | 8.02 Million | -28.45 Million | -17.75 Million | -40.44 Million | -53.68 Million |
| Depreciation & Amortization | 567 Thousand | 901 Thousand | 1.14 Million | 1.4 Million | 2.23 Million | 2.39 Million |
| Deferred income taxes | -518 Thousand | - | 4000.00 | -12.23 Million | -4.25 Million | - |
| Stock-based compensation | 2.19 Million | 1.8 Million | 1.64 Million | 1.25 Million | 1.59 Million | 2.14 Million |
| Change in working capital | 2.91 Million | 2.14 Million | -2.65 Million | -2.4 Million | -2.19 Million | -3.25 Million |
| Other non-cash items | 1.76 Million | -33.89 Million | 6.64 Million | 411 Thousand | 673 Thousand | 988 Thousand |
| Investing Cash Flow | - | -29 Thousand | -713 Thousand | 28.03 Million | 4.09 Million | 72.79 Million |
| Investments in PPE | - | -29 Thousand | -713 Thousand | -88 Thousand | -153 Thousand | -976 Thousand |
| Acquisitions | - | - | - | 28.12 Million | 4.25 Million | 65 Thousand |
| Investment purchases | - | - | - | - | - | -16.53 Million |
| Sales/Maturities of investments | - | - | - | - | - | 90.24 Million |
| Other Investing Activities | - | - | - | 28.12 Million | 4.25 Million | 73.77 Million |
| Financing Cash Flow | 5.99 Million | -2.61 Million | 26.16 Million | 23.87 Million | 20.14 Million | -787 Thousand |
| Debt repayment | -3.46 Million | -12.26 Million | -10.55 Million | -22.1 Million | -137 Thousand | -602 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -10 Thousand | -4000.00 | 10.23 Million | -11 Thousand | -58 Thousand | -808 Thousand |
| Common Stock Issuance | 9.47 Million | 6.93 Million | 11.43 Million | 21.25 Million | 20.34 Million | 623 Thousand |
| Other Financing Activities | -10 Thousand | 2.72 Million | 36.71 Million | 45.97 Million | 58 Thousand | -808 Thousand |
| Accounts receivables | 2.5 Million | 1.16 Million | -1.29 Million | -2.36 Million | -1.8 Million | -3.07 Million |
| Accounts payables | 518 Thousand | -394 Thousand | -1.91 Million | -702 Thousand | -2.69 Million | 1.27 Million |
| Inventory | - | -1.16 Million | 1.29 Million | -1.05 Million | -4.35 Million | -757 Thousand |
| Other working capital | -107 Thousand | 2.53 Million | -740 Thousand | 1.71 Million | 6.66 Million | -694 Thousand |
| Cash at beginning of period | 22.63 Million | 46.3 Million | 42.53 Million | 19.94 Million | 38.08 Million | 17.49 Million |
| Cash at end of period | 16.9 Million | 22.63 Million | 46.3 Million | 42.53 Million | 19.94 Million | 38.08 Million |
| Capital Expenditure | - | -29 Thousand | -713 Thousand | -88 Thousand | -153 Thousand | -976 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.73 Million | -23.66 Million | 3.76 Million | 22.58 Million | -18.13 Million | 20.58 Million |
| Free Cash Flow | -11.73 Million | -21.05 Million | -22.39 Million | -29.4 Million | -42.53 Million | -52.39 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.88 Million | -6.83 Million | -6.19 Million | -18.65 Million | -6.33 Million | -7.94 Million |
| Depreciation & Amortization | 91 Thousand | 106 Thousand | 116 Thousand | 567 Thousand | 123 Thousand | 150 Thousand |
| Deferred income taxes | - | - | -201 Thousand | -518 Thousand | -778 Thousand | 349 Thousand |
| Stock-based compensation | 273 Thousand | 719 Thousand | 358 Thousand | 2.19 Million | 455 Thousand | 465 Thousand |
| Change in working capital | -634 Thousand | -642 Thousand | 176 Thousand | 2.91 Million | -485 Thousand | 2.53 Million |
| Other non-cash items | 1.33 Million | 1.85 Million | 494 Thousand | 1.76 Million | 778 Thousand | -349 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.96 Million | -3000.00 | 3.04 Million | 5.99 Million | 4.34 Million | 481 Thousand |
| Debt repayment | - | - | -3.46 Million | -3.46 Million | - | - |
| Dividends payments | - | - | -8000.00 | - | - | - |
| Common Stock Repurchased | -1000.00 | - | -2000.00 | -10 Thousand | - | - |
| Common Stock Issuance | 3.97 Million | - | 3.04 Million | 9.47 Million | 1.19 Million | 481 Thousand |
| Other Financing Activities | -1000.00 | -3000.00 | -2000.00 | -10 Thousand | 3.14 Million | 481 Thousand |
| Accounts receivables | - | - | -2.5 Million | 2.5 Million | - | - |
| Accounts payables | -879 Thousand | -926 Thousand | 389 Thousand | 518 Thousand | -76 Thousand | 1.11 Million |
| Inventory | - | - | 1.81 Million | - | - | - |
| Other working capital | 245 Thousand | 284 Thousand | -213 Thousand | -107 Thousand | -409 Thousand | 1.41 Million |
| Cash at beginning of period | 10.25 Million | 16.9 Million | 19.11 Million | 22.63 Million | 21 Million | 25.32 Million |
| Cash at end of period | 8.06 Million | 10.25 Million | 16.9 Million | 16.9 Million | 19.11 Million | 21 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.18 Million | -6.65 Million | -2.2 Million | -5.73 Million | -1.89 Million | -4.32 Million |
| Free Cash Flow | -6.15 Million | -6.65 Million | -5.25 Million | -11.73 Million | -6.24 Million | -4.8 Million |
4568
6138
3123
MAHALXSE
603986
BZLYF